Information about medicinal products published on this website is provided for informational purposes only and does not constitute advertising, a public offer, an offer for sale, or instructions for use.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
The use of medicinal products is permitted only upon a doctor’s prescription. Consultations are provided by clinic specialists in person or online in accordance with applicable law.
CHECKUP BLOOD THICKENING
Increased blood viscosity may not manifest symptoms for a long time but can significantly raise the risk of thrombosis, stroke, heart attack, and circulatory disorders. A comprehensive check-up allows for the detection of coagulation system disorders, hereditary predisposition to thrombophilia, inflammatory and metabolic risk factors, as well as provides medical recommendations for further prevention and treatment.
1500у.е.
Our CHECK-UP includes:
Laboratory Tests
Hematological Profile and Blood Rheology:
- Complete blood count with differential.
- Reticulocyte analysis with calculation of the reticulocyte index.
- Coagulogram (extended evaluation of the hemostasis system).
- Prothrombin test (Prothrombin Time [PT], % Quick, INR).
- Activated partial thromboplastin time (aPTT).
- Thrombin time.
- Fibrinogen.
- Antithrombin (activity).
- D-dimer.
- Soluble fibrin monomer complexes (SFMC) (Rödger laboratory, Germany).
- Plasminogen concentration (Rödger laboratory, Germany).
- Protein C (activity).
- Protein S (activity).
Metabolic Factors and Markers of Endothelial Dysfunction
Lipid profile:
- Total cholesterol
- Triglycerides
- HDL cholesterol
- LDL cholesterol
- VLDL cholesterol
- Non-HDL cholesterol
- Atherogenic coefficient
- Apolipoprotein B
- Lipoprotein (a)
- Apolipoprotein A-1
- Glycated hemoglobin (HbA1c)
- HOMA index (glucose + insulin)
Iron Metabolism:
- Serum iron
- Ferritin
- Transferrin
- Total iron-binding capacity (TIBC)
Autoimmune and Inflammatory Profile:
- High-sensitivity C-reactive protein (hs-CRP)
- Lupus anticoagulant
- Anticardiolipin antibodies IgG
- Anticardiolipin antibodies IgM
- Anti-β2-glycoprotein I antibodies IgG
- Anti-β2-glycoprotein I antibodies IgM
Assessment of Inherited Thrombophilia Risk Factors (PCR, Genetics):
- SERPINE1 (PAI-1, 675 5G>4G)
- ITGB3 (β-integrin, 1565 T>C)
- GP1BA (482 C>T)
- FGB (fibrinogen, 455 G>A)
- F13A1 (103 G>T)
- F7 (10976 G>A)
- F5 Leiden (1691 G>A)
- F2 (prothrombin, 20210 G>A)
Folate Cycle Genetics:
- MTRR (66 A>G)
- MTHFR (677 C>T)
- MTHFR (1298 A>C)
- MTR (2756 A>G)
Consultation with Dr. I.V. Perelygin
Medical support throughout all stages of the examination with interpretation of obtained results.
-------------------------------------------
Preparation for the Examination:
Blood samples must be taken strictly in the morning on an empty stomach, optimally between 08:00 and 11:00.
The fasting period before the test should be 10–12 hours. During this time, only plain still water is allowed.
Alcohol consumption must be completely avoided for 24 hours before the test, and intense physical activities (workouts, heavy lifting) should be avoided.
Within 12 hours prior to blood sampling, fatty, spicy, and fried foods should be excluded from the diet, and overeating should be avoided.
Refrain from smoking for 1–2 hours before specimen collection.
Immediately before the procedure, it is recommended to sit quietly for 15–20 minutes to stabilize circulatory parameters.
Additional Recommendations:
Adequate hydration is crucial the day before the test. Dehydration leads to blood thickening (hemoconcentration), which can artificially raise hematocrit and blood viscosity values.
The intake of any medications must be coordinated with your attending physician. If you are taking drugs that affect the coagulation system (antiplatelets, anticoagulants including aspirin, heparins, warfarin, or direct oral anticoagulants), as well as hormone replacement therapy or oral contraceptives, you must inform the laboratory staff. This information should be specified in the test referral.
If discontinuation of anticoagulant therapy is impossible, blood sampling should be performed strictly before taking the next morning dose of the medication.
Laboratory Tests
Hematological Profile and Blood Rheology:
- Complete blood count with differential.
- Reticulocyte analysis with calculation of the reticulocyte index.
- Coagulogram (extended evaluation of the hemostasis system).
- Prothrombin test (Prothrombin Time [PT], % Quick, INR).
- Activated partial thromboplastin time (aPTT).
- Thrombin time.
- Fibrinogen.
- Antithrombin (activity).
- D-dimer.
- Soluble fibrin monomer complexes (SFMC) (Rödger laboratory, Germany).
- Plasminogen concentration (Rödger laboratory, Germany).
- Protein C (activity).
- Protein S (activity).
Metabolic Factors and Markers of Endothelial Dysfunction
Lipid profile:
- Total cholesterol
- Triglycerides
- HDL cholesterol
- LDL cholesterol
- VLDL cholesterol
- Non-HDL cholesterol
- Atherogenic coefficient
- Apolipoprotein B
- Lipoprotein (a)
- Apolipoprotein A-1
- Glycated hemoglobin (HbA1c)
- HOMA index (glucose + insulin)
Iron Metabolism:
- Serum iron
- Ferritin
- Transferrin
- Total iron-binding capacity (TIBC)
Autoimmune and Inflammatory Profile:
- High-sensitivity C-reactive protein (hs-CRP)
- Lupus anticoagulant
- Anticardiolipin antibodies IgG
- Anticardiolipin antibodies IgM
- Anti-β2-glycoprotein I antibodies IgG
- Anti-β2-glycoprotein I antibodies IgM
Assessment of Inherited Thrombophilia Risk Factors (PCR, Genetics):
- SERPINE1 (PAI-1, 675 5G>4G)
- ITGB3 (β-integrin, 1565 T>C)
- GP1BA (482 C>T)
- FGB (fibrinogen, 455 G>A)
- F13A1 (103 G>T)
- F7 (10976 G>A)
- F5 Leiden (1691 G>A)
- F2 (prothrombin, 20210 G>A)
Folate Cycle Genetics:
- MTRR (66 A>G)
- MTHFR (677 C>T)
- MTHFR (1298 A>C)
- MTR (2756 A>G)
Consultation with Dr. I.V. Perelygin
Medical support throughout all stages of the examination with interpretation of obtained results.
-------------------------------------------
Preparation for the Examination:
Blood samples must be taken strictly in the morning on an empty stomach, optimally between 08:00 and 11:00.
The fasting period before the test should be 10–12 hours. During this time, only plain still water is allowed.
Alcohol consumption must be completely avoided for 24 hours before the test, and intense physical activities (workouts, heavy lifting) should be avoided.
Within 12 hours prior to blood sampling, fatty, spicy, and fried foods should be excluded from the diet, and overeating should be avoided.
Refrain from smoking for 1–2 hours before specimen collection.
Immediately before the procedure, it is recommended to sit quietly for 15–20 minutes to stabilize circulatory parameters.
Additional Recommendations:
Adequate hydration is crucial the day before the test. Dehydration leads to blood thickening (hemoconcentration), which can artificially raise hematocrit and blood viscosity values.
The intake of any medications must be coordinated with your attending physician. If you are taking drugs that affect the coagulation system (antiplatelets, anticoagulants including aspirin, heparins, warfarin, or direct oral anticoagulants), as well as hormone replacement therapy or oral contraceptives, you must inform the laboratory staff. This information should be specified in the test referral.
If discontinuation of anticoagulant therapy is impossible, blood sampling should be performed strictly before taking the next morning dose of the medication.
